Clinical Trial: Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: A Randomized, Double-Blind, Vehicle Controlled, Parallel Group Study of the Dose-Response Profile of A-101 Topical Solution in Subjects With Seborrheic Keratosis.
Brief Summary: The main objective of this study is to evaluate the dose-response relationship of two concentrations of A-101 solution when applied to individual seborrheic keratosis (SK) lesions (target lesions) compared with a matching A-101 Solution Vehicle.
Detailed Summary:
The main objective of this study is to evaluate the dose-response relationship of two concentrations of A-101solution when applied to individual seborrheic keratosis (SK) lesions (target lesions) compared with a matching A-101 Solution Vehicle.
Each subject will have 4 target lesions on the trunk/extremities.
A further objective is to evaluate the safety and efficacy of two concentrations of A-101 solution and its matching vehicle when applied to SK target lesions on the trunk/extremities.
Sponsor: Aclaris Therapeutics, Inc.
Current Primary Outcome: Physician's Lesion Assessment [ Time Frame: 16 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Physician's Lesion Assessment [ Time Frame: 16 weeks ]
Original Secondary Outcome: Same as current
Information By: Aclaris Therapeutics, Inc.
Dates:
Date Received: June 6, 2014
Date Started: June 2014
Date Completion: December 2014
Last Updated: October 7, 2014
Last Verified: June 2014